paroxetine has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Y; Hu, S; Sun, W; Wang, L; Wang, Q; Wang, R; Wang, X; Wei, W; Wu, L; Wu, Y; Zhang, L; Zhang, M | 1 |
| Abo-Saif, AA; Mohamed, WR; Shafiey, SI | 1 |
2 other study(ies) available for paroxetine and Adjuvant Arthritis
| Article | Year |
|---|---|
Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cell Movement; Chemokine CX3CL1; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; Immunosuppressive Agents; Interleukin-1beta; Lymphocyte Activation; Male; Methotrexate; Paroxetine; Rats; Rats, Wistar; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer; Tumor Necrosis Factor-alpha | 2017 |
Paroxetine and rivastigmine mitigates adjuvant-induced rheumatoid arthritis in rats: Impact on oxidative stress, apoptosis and RANKL/OPG signals.
Topics: Animals; Apoptosis; Arthritis, Experimental; Biomarkers; Female; Gene Expression Regulation; Neuroprotective Agents; Osteoprotegerin; Oxidative Stress; Paroxetine; RANK Ligand; Rats; Rivastigmine; Selective Serotonin Reuptake Inhibitors | 2018 |